Combined treatment of acute promyelocytic leukemia (APL) cell line HL-60 with melatonin and retinoic acid decreases VDAC1 expression, suggesting its leukemia-promoting role (189). This evidence concerns the gene VDAC1 and acute promyelocytic leukemia.